UNICHEM LAB Surges by 5%; BSE HEALTHCARE Index Down 1.4%
May 17, 2019 03:20 PM

UNICHEM LAB share price has zoomed 5% and is presently trading at Rs 185.

Meanwhile, the BSE HEALTHCARE Index is at 13,328 (down 1.4%).

Among the top Gainers in the BSE HEALTHCARE Index today are UNICHEM LAB (up 5.1%) and CAPLIN POINT (up 7.1%).

GLENMARK PHARMA and GSK PHARMA (down 0.3%) are among the top losers today.

Over the last one year, UNICHEM LAB has moved down from Rs 262 to Rs 185, registering a loss of Rs 78 (down 29.5%).

On the other hand, the BSE HEALTHCARE has moved up from 13,285 to 13,328, registering a gain of 43 points (up -1.0%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DIVIS LABORATORIES (up 39.4%), DR. REDDYS LAB (up 34.1%) and SUVEN LIFESCIENCES (up 32.8%).

What About the Benchmark Indices?

The BSE Sensex is at 37,945 (up 1.3%).

The top gainers among the BSE Sensex stocks today are BAJAJ FINANCE (up 6.0%), HERO MOTOCORP (up 4.0%) and BAJAJ AUTO (up 3.4%). Other gainers include MARUTI SUZUKI (up 3.3%) and KOTAK MAHINDRA BANK (up 3.2%). The most traded stocks in the BSE Sensex are ICICI BANK and TATA MOTORS.

In the meantime, NSE Nifty is at 11,416 (up 1.3%). ZEE ENTERTAINMENT (up 7.7%) and BAJAJ FINANCE (up 6.1%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,388 to 37,945, registering a gain of 2,557 points (up 7.1%).

UNICHEM LAB Financial Update...

UNICHEM LAB net profit declined 110.9% YoY to Rs 63 million for the quarter ended December 2018, compared to a loss of Rs 580 million a year ago. Net Sales rose 53.8% to Rs 2.4 billion during the period as against Rs 1.6 billion in October-December 2017.

For the year ended March 2018, UNICHEM LAB reported 87.4% increase in net profit to Rs 1.3 billion compared to net loss of Rs 709.0 million during FY17.

Revenue of the company grew 17.1% to Rs 8 billion during FY18.

The current Price to earnings ratio of UNICHEM LAB, based on rolling 12 month earnings, stands at 211.4x.